Jiangsu Bioperfectus Technologies Co Ltd (688399) - Total Liabilities

Latest as of September 2025: CN¥681.04 Million CNY ≈ $99.66 Million USD

Based on the latest financial reports, Jiangsu Bioperfectus Technologies Co Ltd (688399) has total liabilities worth CN¥681.04 Million CNY (≈ $99.66 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Jiangsu Bioperfectus Technologies Co Ltd's assets to evaluate the company's liquid asset resilience ratio.

Jiangsu Bioperfectus Technologies Co Ltd - Total Liabilities Trend (2016–2024)

This chart illustrates how Jiangsu Bioperfectus Technologies Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Jiangsu Bioperfectus Technologies Co Ltd total assets.

Jiangsu Bioperfectus Technologies Co Ltd Competitors by Total Liabilities

The table below lists competitors of Jiangsu Bioperfectus Technologies Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Biofarm Bucure RO:BIO	Romania	RON85.86 Million
Horizon Technology Finance NASDAQ:HRZN	USA	$457.78 Million
Balmer Lawrie & Company Limited NSE:BALMLAWRIE	India	Rs12.69 Billion
Lands’ End Inc NASDAQ:LE	USA	$404.58 Million
Shanghai Lisheng Racing Co Ltd SHE:002858	China	CN¥361.38 Million
Shenke Slide Bearing Corp SHE:002633	China	CN¥374.40 Million
Beijing Fjr Optoelectronic Technology Co Ltd SHG:688272	China	CN¥304.51 Million
Shenzhen New Land Co Ltd SHE:300778	China	CN¥200.87 Million

Liability Composition Analysis (2016–2024)

This chart breaks down Jiangsu Bioperfectus Technologies Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 688399 equity to assets ratio to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.32	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.23	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.19	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Jiangsu Bioperfectus Technologies Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Jiangsu Bioperfectus Technologies Co Ltd (2016–2024)

The table below shows the annual total liabilities of Jiangsu Bioperfectus Technologies Co Ltd from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥489.32 Million ≈ $71.60 Million	-2.39%
2023-12-31	CN¥501.31 Million ≈ $73.36 Million	-54.95%
2022-12-31	CN¥1.11 Billion ≈ $162.84 Million	+15.57%
2021-12-31	CN¥962.89 Million ≈ $140.90 Million	+57.03%
2020-12-31	CN¥613.18 Million ≈ $89.73 Million	+359.06%
2019-12-31	CN¥133.57 Million ≈ $19.55 Million	+86.91%
2018-12-31	CN¥71.46 Million ≈ $10.46 Million	+41.88%
2017-12-31	CN¥50.37 Million ≈ $7.37 Million	+47.74%
2016-12-31	CN¥34.09 Million ≈ $4.99 Million	--

About Jiangsu Bioperfectus Technologies Co Ltd

SHG:688399 China Biotechnology

Market Cap

$309.53 Million

CN¥2.12 Billion CNY

Market Cap Rank

#14787 Global

#4419 in China

Share Price

CN¥25.22

Change (1 day)

+1.73%

52-Week Range

CN¥23.79 - CN¥84.90

All Time High

CN¥419.88